Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
9th Advances Against Aspergillosis and Mucormycosis Conference
February 28, 2020
NAC Comms team becomes NAC CARES team
February 27, 2020
World Aspergillosis Day 2020
February 3, 2020
Hope on the horizon: Novel antifungal treatments in development
January 20, 2020
How can I protect myself from air pollution?
January 17, 2020
‘Smart shirt’ used to monitor lung function
December 4, 2019
Bedding, allergies and lung health
December 2, 2019
The importance of measles vaccination
November 8, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video